Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechanism

Keyphrases

• Macrophage Inflammatory Protein 1α 100%
• Adrenoceptors 100%
• Endogenous Catecholamines 100%
• Noradrenaline 27%
• Isoproterenol 27%
• Adrenoceptor Agonist 27%
• Rolipram 27%
• Propranolol 18%
• Catecholamines 18%
• LPS-induced Inflammation 18%
• Cyclic Adenosine Monophosphate (cAMP) 18%
• Adrenoceptor Antagonist 18%
• Adrenaline 18%
• Noradrenaline and Adrenaline 18%
• Inflammation 9%
• Prostaglandin E2 9%
• Inhibitory Effect 9%
• Chemokines 9%
• Neurotransmitters 9%
• Lipopolysaccharide 9%
• Cytokine Production 9%
• Peritoneal Macrophages 9%
• Bacterial Lipopolysaccharide 9%
• Concentration-dependent 9%
• Phenylephrine 9%
• Plasma Parameters 9%
• Northern Blot Analysis 9%
• RAW264.7 Macrophages 9%
• Phentolamine 9%
• Thioglycolate 9%
• Phosphodiesterase Inhibitors 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Catecholamine 100%
• Macrophage Inflammatory Protein 1 100%
• Adrenergic Receptor 100%
• Noradrenalin 45%
• Epinephrine 36%
• Adrenergic Receptor Stimulating Agent 27%
• Isoprenaline 27%
• Rolipram 27%
• Propranolol 18%
• Cyclic AMP 18%
• Inflammation 9%
• Cytokine 9%
• Chemokine 9%
• Neurotransmitter 9%
• Bacterium Lipopolysaccharide 9%
• Prostaglandin E2 9%
• Phenylephrine 9%
• Phentolamine 9%
• Phosphodiesterase IV Inhibitor 9%
• Thioglycolic Acid 9%
• Messenger RNA 9%